Wellnex Life (ASX:WNX) - CEO, George Karafotias
CEO, George Karafotias
Source: Wellnex Life
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Wellnex Life (WNX) signs agreement to supply its soft gel liquid paracetamol to GLaxoSmithKline (GSK) Consumer Trading Services (CTS)
  • A subsidiary of GSK Consumer Healthcare, CSK CTS will retail WNX’s product under its pain relief brand in Australia and New Zealand
  • Throughout the three-year agreement, Wellnex will be responsible for manufacturing the products
  • WNX CEO George Karafotias says the deal was testament to the work of recently acquired, Brand Solutions Australia, which has been working to secure this agreement
  • Shares have been trading grey at 8.2 cents at market open

Wellnex Life (WNX) has signed an agreement to supply its soft gel liquid paracetamol to GlaxoSmithKline (GSK) Consumer Trading Services (CTS).

GSK CTS is a subsidiary of GSK Consumer Healthcare which is one of the world’s largest and leading global consumer healthcare companies known for its brands which include Panadol, Sensodyne, Voltaren, Polident, Centrum, Otrivin and Advil.

Under the new supply agreement, GSK will retail Wellnex’s product under its pain relief brand in Australia and New Zealand.

Throughout the three year agreement, Wellnex will be responsible for manufacturing the products.

According to Wellnex, this agreement is part of its business model to health and wellness products first or fast to the market.

Director of Wellnex Life Zack Bozinovsk said partnering with a subsidiary of a leading healthcare company is exciting, and WNX looks forward to working with GSK.

CEO George Karafotias added that the deal was testament in particular to the work of its recently acquired company, Brand Solutions Australia, which has reportedly been working with GSK Consumer Healthcare for over 12 months to secure this agreement.

Shares were trading grey at 8.2 cents at market open.

wnx by the numbers
More From The Market Online
The Market Online Video

Market Close: ASX slides as resources and miners lead broad market sell-off

The Australian sharemarket came under renewed pressure on Tuesday 17th Nov, with selling extending across almost every sector as resources and energy

Mayne Pharma agrees to $604m takeover as Gedeon Richter offers 99% premium to shareholders

Mayne Pharma has agreed to a $604 million takeover by Gedeon Richter, offering shareholders $6.40 per…

QEM identifies new antimony-gold targets at historic US tungsten mine

QEM Limited identifies two new antimony-gold exploration targets at its historic Big It Tungsten Project in…

Hot Chili continues to grow La Verde with another big drill result

Hot Chili has obtained further strong drilling results ahead of a maiden MRE for its La…